Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C

European Journal of Internal Medicine

Volumn 24, Issue 8, 2013, Pages 846-851

  Gavilán, Juan Carlos ^a   Ojeda, Guillermo ^a   Arnedo, Rocio ^a   Puerta, Susana ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Hepatocellular carcinoma; Liver cancer; Predictive score; Risk factors; Surveillance program; Viral hepatitis

Indexed keywords

ALPHA FETOPROTEIN; IMMUNOGLOBULIN;

ADULT; AGE; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; FEMALE; HCC 4 RISK SCORE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KAPLAN MEIER METHOD; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

HEPATOCELLULAR CARCINOMA; LIVER CANCER; PREDICTIVE SCORE; RISK FACTORS; SURVEILLANCE PROGRAM; VIRAL HEPATITIS;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84889651732     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.06.010     Document Type: Article

References (28)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. G.S. Qian, R.K. Ross, M.C. Yu, J.M. Yuan, Y.T. Gao, and B.E. Henderson A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China Cancer Epidemiol Biomarkers Prev 3 1994 3 10
3. F. Donato, A. Tagger, U. Gelatti, G. Parrinello, P. Boffetta, and A. Albertini Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women Am J Epidemiol 155 2002 323 331
4. S. Fargion, A.L. Fracanzani, A. Piperno, M. Braga, R. D'Alba, and G. Ronchi Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis Hepatology 20 1994 1426 1431
5. E. Hashimoto, S. Yatsuji, M. Tobari, M. Taniai, N. Torii, and K. Tokushige Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis J Gastroenterol 44 2009 89 95
6. M.S. Ascha, I.A. Hanouneh, R. Lopez, T.A. Tamimi, A.F. Feldstein, and N.N. Zein The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
7. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
8. H.I. Yang, S.N. Lu, Y.F. Liaw, S.L. You, C.A. Sun, and L.Y. Wang Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174
9. J.A. Davila, R.O. Morgan, Y. Shaib, K.A. McGlynn, and H.B. El-Serag Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study Gastroenterology 127 2004 1372 1380
10. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
11. G. Torzilli, M. Minagawa, T. Takayama, K. Inoue, A.M. Hui, and K. Kubota Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy Hepatology 30 1999 889 893
12. J. Bruix, and J.M. Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
13. D. Cox Regression models and life tables (with discussion) J R Stat Soc B 34 1972 187 220
14. P.J. Heagerty, T. Lumley, and M.S. Pepe Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 56 2000 337 344
15. B.H. Zhang, B.H. Yang, and Z.Y. Tang Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 2004 417 422
16. H.I. Yang, M. Sherman, J. Su, P.J. Chen, Y.F. Liaw, and U.H. Iloeje Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection J Clin Oncol 28 2010 2437 2444
17. R.F. Velazquez, M. Rodriguez, C.A. Navascues, A. Linares, R. Perez, and N.G. Sotorrios Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527
18. M.F. Yuen, Y. Tanaka, D.Y. Fong, J. Fung, D.K. Wong, and J.C. Yuen Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol 50 2009 80 88
19. P.A. Bonis, M.J. Tong, L.M. Blatt, A. Conrad, and J.L. Griffith A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C Am J Gastroenterol 94 1999 1605 1612
20. M. Kurosaki, N. Hiramatsu, M. Sakamoto, Y. Suzuki, M. Iwasaki, and A. Tamori Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C J Hepatol 56 2012 602 628
21. A.S. Lok, L.B. Seeff, T.R. Morgan, A.M. di Bisceglie, R.K. Sterling, and T.M. Curto Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease Gastroenterology 136 2009 138 148
22. L.S. Park, J.P. Tate, A.C. Justice, V. Lo Re III, J.K. Lim, and N. Brau FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients Cancer Epidemiol Biomarkers Prev 20 2011 2512 2517
23. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
24. Y. Sato, K. Nakata, Y. Kato, M. Shima, N. Ishii, and T. Koji Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein N Engl J Med 328 1993 1802 1806
25. A. Cristani, G. Cioni, E. Tincani, and E. Ventura Normal gamma globulin levels in liver cirrhosis: a prognostic indicator and improved survival Recenti Prog Med 82 1991 9 12
26. A. Vallet-Pichard, V. Mallet, B. Nalpas, V. Verkarre, A. Nalpas, and V. Dhalluin-Venier FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest Hepatology 46 2007 32 36
27. A.A. Shaheen, and R.P. Myers Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review Hepatology 46 2007 912 921
28. X. Forns, S. Ampurdanes, J.M. Llovet, J. Aponte, L. Quinto, and E. Martinez-Bauer Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992